Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BROMOCRIPTINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1149 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zenzola, A; Diroma, C; Fraddosio, A; Lamberti, S; Moramarco, A; Palagano, G; Iliceto, G
      Efficacy and tolerability of dopamine agonists in a parkinsonian population

      NEUROLOGICAL SCIENCES
    2. Alarcon-Segovia, D
      The future of treatment for systemic lupus erythematosus

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    3. Erb, N; Pace, AV; Delamere, JP; Kitas, GD
      Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline

      RHEUMATOLOGY
    4. Hamed, H; Fentiman, IS
      2. Benign breast disease

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    5. Stefaneanu, L; Kovacs, K; Horvath, E; Buchfelder, M; Fahlbusch, R; Lancranjan, I
      Dopamine D2 receptor gene expression in human adenohypophysial adenomas

      ENDOCRINE
    6. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    7. Caraceni, T; Musicco, M
      Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study

      PARKINSONISM & RELATED DISORDERS
    8. Weiner, WJ; Factor, SA; Jankovic, J; Hauser, RA; Tetrud, JW; Waters, CH; Shulman, LM; Glassman, PM; Beck, B; Paume, D; Doyle, C
      The long-term safety and efficacy of pramipexole in advanced Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    9. Shimbo, T; Hira, K; Takemura, M; Fukui, T
      Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan

      PHARMACOECONOMICS
    10. Le, WD; Jankovic, J
      Are dopamine receptor agonists neuroprotective in Parkinson's disease?

      DRUGS & AGING
    11. Walker, SE
      Modulation of hormones in the treatment of lupus

      AMERICAN JOURNAL OF MANAGED CARE
    12. Itoh, J; Kawai, T; Serizawa, A; Yamamoto, Y; Ogawa, K; Matsuno, A; Watanabe, K; Osamura, RY
      Three-dimensional imaging of hormone-secreting cells and their microvesselenvironment in estrogen-induced prolactinoma of the rat pituitary gland byconfocal laser scanning microscopy

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    13. Malcolm, R; Herron, J; Sutherland, SE; Brady, KT
      Adverse outcomes in a controlled trial of pergolide for cocaine dependence

      JOURNAL OF ADDICTIVE DISEASES
    14. Frohman, LA
      Pituitary tumors in pregnancy

      ENDOCRINOLOGIST
    15. Lee, JI; Shin, HJ; Nam, DH; Kim, JS; Hong, SC; Shin, HJ; Park, K; Eoh, W; Kim, JH; Lee, WY
      Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine

      JOURNAL OF KOREAN MEDICAL SCIENCE
    16. Jacobi, AM; Rohde, W; Ventz, M; Riemekasten, G; Burmester, GR; Hiepe, F
      Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity

      LUPUS
    17. Hrycek, A; Cieslik, P; Tustanowski, J; Nowak, S; Jedynak, P
      Selected serum cytokines in systemic lupus erythematosus treated with quinagolide

      LUPUS
    18. Walker, SE
      Treatment of systemic lupus erythematosus with bromocriptine

      LUPUS
    19. Tansey, MJ; Schlechte, JA
      Pituitary production of prolactin and prolactin-suppressing drugs

      LUPUS
    20. McMurray, RW
      Prolactin in murine systemic lupus erythematosus

      LUPUS
    21. Walker, SE
      Bromocriptine treatment of systemic lupus erythematosus

      LUPUS
    22. Lieberman, A; Minagar, A; Pinter, MM
      The efficacy of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    23. Armer, JA; Martin, WRW; Pogarell, O
      Tolerability and safety profile of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    24. MohanKumar, PS; MohanKumar, SMJ; Quadri, SK; Voogt, JL
      Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats

      JOURNAL OF NEUROENDOCRINOLOGY
    25. Westin, JE; Andersson, M; Lundblad, M; Cenci, MA
      Persistent changes in striatal gene expression induced by long-term L-DOPAtreatment in a rat model of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROSCIENCE
    26. Micieli, G; Cavallini, A; Marcheselli, S; Mailland, F; Ambrosoli, L; Nappi, G
      Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    27. Althaus, M; de Mey, C; Ezan, E; Ciecko-Michalska, I; Kostka-Trabkal, E; Goszcz, A; Retzow, A
      Plasma and urine, pharmacokinetics of the dopamine agonist alpha-dihydroergocryptine in patients with hepatic dysfunction

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    28. Kooistra, HS; Okkens, AC
      Secretion of prolactin and growth hormone in relation to ovarian activity in the dog

      REPRODUCTION IN DOMESTIC ANIMALS
    29. Miki, N
      Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia

      INTERNAL MEDICINE
    30. Bracero, N; Zacur, HA
      Polycystic ovary syndrome and hyperprolactinemia

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    31. Molitch, ME
      Disorders of prolactin secretion

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    32. Halikas, JA; Center, BA; Pearson, VL; Carlson, GA; Crea, F
      A pilot, open clinical study of depakote in the treatment of cocaine abuse

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    33. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    34. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    35. Ahlskog, JE; Muenter, MD
      Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

      MOVEMENT DISORDERS
    36. Montastruc, JL; Desboeuf, K; Lapeyre-Mestre, M; Senard, JM; Rascol, O; Brefel-Courbon, C
      Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease

      MOVEMENT DISORDERS
    37. Ty, EB; Rothner, AD
      Neuroleptic malignant syndrome in children and adolescents

      JOURNAL OF CHILD NEUROLOGY
    38. Petrossians, P; Ronci, N; Socin, HV; Kalife, A; Stevenaert, A; Bloch, B; Tabarin, A; Beckers, A
      ACTH silent adenoma shrinking under cabergoline

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    39. Williams, D; Lewis, J; McBride, A
      A comparison of rating scales for the alcohol-withdrawal syndrome

      ALCOHOL AND ALCOHOLISM
    40. van der Kolk, JH; Ijzer, J; Overgaauw, PAM; van der Linde-Sipman, JS
      Pituitary-independent Cushing's syndrome in a horse

      EQUINE VETERINARY JOURNAL
    41. Kadioglu, P; Acbay, O; Demir, G; Gazioglu, N; Gundogdu, S
      The effect of prolactin and bromocriptine on human peripheral immune status

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    42. Cappabianca, P; Lodrini, S; Felisati, G; Peca, C; Cozzi, R; Di Sarno, A; Cavallo, LM; Giombini, S; Colao, A
      Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    43. De Menis, E; Visentin, A; Billeci, D; Tramontin, P; Agostini, S; Marton, E; Conte, N
      Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    44. Kumandas, S; Casken, H; Ciftci, A; Ozturk, M; Per, H
      Lamotrigine in two cases of Rett syndrome

      BRAIN & DEVELOPMENT
    45. Ricci, G; Giolo, E; Nucera, G; Pozzobon, C; De Seta, F; Guaschino, S
      Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: Report of two cases and review of the literature

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    46. Ranaldi, R; Wang, ZX; Woolverton, WL
      Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys

      DRUG AND ALCOHOL DEPENDENCE
    47. de los Cobos, JP; Duro, P; Trujols, J; Tejero, A; Batlle, F; Ribalta, E; Casas, M
      Methadone tapering plus amantadine to detoxify heroin-dependent inpatientswith or without an active cocaine use disorder: two randomised controlled trials

      DRUG AND ALCOHOL DEPENDENCE
    48. Tanaka, K; Miyazaki, I; Fujita, N; Haque, ME; Asanuma, M; Ogawa, N
      Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist

      NEUROCHEMICAL RESEARCH
    49. Jankovic, J; Tan, EK
      Choosing dopamine agonists in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    50. Minea, D; Varga, I; Falup-Pecurariu, C; de Mey, C; Retzow, A; Althaus, M
      Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    51. Jansen, PAF; Herings, RMC; Samson, MM; De Vreede, PL; Schuurmans-Daemen, LMPJ; Hovestadt, A; Verhaar, HJJ; Van Laar, T
      Quick titration of pergolide in cotreatment with domperidone is safe and effective

      CLINICAL NEUROPHARMACOLOGY
    52. Montastruc, JL; Brefel-Courbon, C; Senard, JM; Bagheri, H; Ferreira, J; Rascol, O; Lapeyre-Mestre, M
      Sleep attacks and antiparkinsonian drugs: A pilot prospective pharmacoepidemiologic study

      CLINICAL NEUROPHARMACOLOGY
    53. Ribbing, M; Reinecke, H; Breithardt, G; Kerber, S
      Acute anterior wall myocardial infarction in a 31-year-old patient after receiving methylergometrine for peripartal vaginal bleeding

      HERZ
    54. Leanos-Miranda, A; Pascoe-Lira, D; Chavez-Rueda, KA; Blanco-Favela, F
      Antiprolactin autoantibodies in systemic lupus erythematosus: Frequency and correlation with prolactinemia and disease activity

      JOURNAL OF RHEUMATOLOGY
    55. Pacilio, M; Migliaresi, S; Meli, R; Ambrosone, L; Bigliardo, B; Di Carlo, R
      Elevated bioactive prolactin levels in systemic lupus erythematosus - Association with disease activity

      JOURNAL OF RHEUMATOLOGY
    56. Liang, Y; Cincotta, AH
      Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice

      INTERNATIONAL JOURNAL OF OBESITY
    57. Knight, CH
      Overview of prolactin's role in farm animal lactation

      LIVESTOCK PRODUCTION SCIENCE
    58. Mungersdorf, M; Sommer, U; Sommer, M; Reichmann, H
      High-dose therapy with ropinirole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    59. Hanna, PA; Ratkos, L; Ondo, WG; Jankovic, J
      Switching from pergolide to pramipexole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    60. Fassnacht, M; Capeller, B; Arlt, W; Steck, T; Allolio, B
      Octreotide LAR (R) treatment throughout pregnancy in an acromegalic woman

      CLINICAL ENDOCRINOLOGY
    61. Kiortsis, DN; Argyropoulou, MI; Efremidis, SC; Tsatsoulis, A
      Hyperprolactinaemia induced by a nonsecreting pituitary adenoma: differential diagnosis with magnetization transfer MRI technique

      CLINICAL ENDOCRINOLOGY
    62. Ferone, D; Pivonello, R; Lastoria, S; Faggiano, A; de Caro, MLD; Cappabianca, P; Lombardi, G; Colao, A
      In vivo and in vitro effects of octreotide, quinagolide and cabergoline infour hyperprolactinaemic acromegalics: Correlation with somatostatin and dopamine D-2 receptor scintigraphy

      CLINICAL ENDOCRINOLOGY
    63. Karunakaran, S; Page, RCL; Wass, JAH
      The effect of the menopause on prolactin levels in patients with hyperprolactinaemia

      CLINICAL ENDOCRINOLOGY
    64. Andersen, M; Bjerre, P; Schroder, HD; Edal, A; Hoilund-Carlsen, PF; Pedersen, PH; Hagen, C
      In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas

      CLINICAL ENDOCRINOLOGY
    65. Kemink, SAG; Grotenhuis, JA; De Vries, J; Pieters, GFFM; Hermus, ARMM; Smals, AGH
      Management of Nelson's syndrome: observations in fifteen patients

      CLINICAL ENDOCRINOLOGY
    66. Marcos, L; De Luis, DA; Botella, I; Hurtado, A
      Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma

      CLINICAL ENDOCRINOLOGY
    67. Wada, T; Kanno, M; Aoshima, T; Otani, K
      Dose-dependent augmentation effect of bromocriptine in a case with refractory depression

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    68. Tuite, P; Ebbitt, B
      Dopamine agonists

      SEMINARS IN NEUROLOGY
    69. Ishige, K; Chen, Q; Sagara, Y; Schubert, D
      The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death

      JOURNAL OF NEUROSCIENCE
    70. Hillefors, M; von Euler, G
      Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen

      NEUROCHEMISTRY INTERNATIONAL
    71. Delaforge, M; Bouille, C; Jaouen, M; Jankowski, CK; Lamouroux, C; Bensoussan, C
      Recognition and oxidative metabolism of cyclodipeptides by hepatic cytochrome P450

      PEPTIDES
    72. Perugi, G; Toni, C; Ruffolo, G; Frare, F; Akiskal, H
      Adjunctive dopamine agonists in treatment-resistant bipolar II depression:an open case series

      PHARMACOPSYCHIATRY
    73. Rushen, J; Robert, S; Farmer, C
      Evidence of a limited role for prolactin in the preparturient activity of confined gilts

      APPLIED ANIMAL BEHAVIOUR SCIENCE
    74. Nomikos, P; Buchfelder, M; Fahlbusch, R
      Current management of prolactinomas

      JOURNAL OF NEURO-ONCOLOGY
    75. Herak-Perkovic, V; Grabarevic, Z; Banic, M; Anic, B; Novosel, V; Pogacnik, M
      Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice

      JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
    76. Sutton, MA; Rolfe, NG; Beninger, RJ
      Biphasic effects of 7-OH-DPAT on the acquisition of responding for conditioned reward in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    77. Ribeiro-De-Oliveira, A; Guerra, RM; Foscolo, RB; Marubayashi, U; dos Reis, AM; Coimbra, CC
      Bromocriptine-induced dissociation of hyperglycemia and prolactin responseto restraint

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    78. McMurray, RW
      Bromocriptine in rheumatic and autoimmune diseases

      SEMINARS IN ARTHRITIS AND RHEUMATISM
    79. Kirsch, C; Iffy, L; Zito, GE; McArdle, JJ
      The role of hypertension in bromocriptine-related puerperal intracranial hemorrhage

      NEURORADIOLOGY
    80. Lees, AJ; Katzenschlager, R; Head, J; Ben-Shlomo, Y
      Ten-year follow-up of three different initial treatments in de-novo PD - Arandomized trial

      NEUROLOGY
    81. Boyce, S; Rupniak, NMJ; Steventon, MJ; Iversen, SD
      Differential effects of D-1 and D-2 agonists in MPTP,treated primates: Functional implications for Parkinson's disease

      NEUROLOGY
    82. Rice, JE; Thompson, PD
      Movement disorders I: Parkinsonism and the akinetic-rigid syndromes

      MEDICAL JOURNAL OF AUSTRALIA
    83. Mendes, MC; Ferriani, RA; Sala, MM; Moura, MD; Carrara, HHA; de Sa, MFS
      Effect of transitory hyperprolactinemia on in vitro fertilization of humanoocytes

      JOURNAL OF REPRODUCTIVE MEDICINE
    84. Bilic, I; Zoricic, I; Anic, T; Separovic, J; Stancic-Rokotov, D; Mikus, D; Buljat, G; Ivankovic, D; Aralica, G; Prkacin, I; Perovic, D; Mise, S; Rotkvic, I; Petek, M; Rucman, R; Seiwerth, S; Sikiric, P
      Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice

      LIFE SCIENCES
    85. Trottenberg, T; Paul, G; Meissner, W; Maier-Hauff, K; Taschner, C; Kupsch, A
      Pallidal and thalamic neurostimulation in severe tardive dystonia

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    86. Shimon, I; Rubinek, T; Bar-Hava, I; Nass, D; Hadani, M; Amsterdam, A; Harel, G
      Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    87. Roberts, RL; Jenkins, KT; Lawler, T; Wegner, FH; Newman, JD
      Bromocriptine administration lowers serum prolactin and disrupts parental responsiveness in common marmosets (Callithrix j. jacchus)

      HORMONES AND BEHAVIOR
    88. Lee, EJ; Duan, WR; Jakacka, M; Gehm, BD; Jameson, JL
      Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cellsand inhibits tumor growth in nude mice

      ENDOCRINOLOGY
    89. de Mey, C; Althaus, M; Ezan, E; Retzow, A
      Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    90. Pi, XJ; Voogt, JL
      Mechanisms for suckling-induced changes in expression of prolactin receptor in the hypothalamus of the lactating rat

      BRAIN RESEARCH
    91. Passler, MA; Riggs, RV
      Positive outcomes in traumatic brain injury-vegetative state: Patients treated with bromocriptine

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    92. Thorley, RR; Wertsch, JJ; Klingbeil, GE
      Acute hypothalamic instability in traumatic brain injury: A case report

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    93. Raymer, AM; Bandy, D; Adair, JC; Schwartz, RL; Williamson, DJG; Rothi, LJG; Heilman, KM
      Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    94. Rascol, O; Nutt, JG; Blin, O; Goetz, CG; Trugman, JM; Soubrouillard, C; Carter, JH; Currie, LJ; Fabre, N; Thalamas, C; Giardina, WJ; Wright, S
      Induction by dopamine D-1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease

      ARCHIVES OF NEUROLOGY
    95. Jacobi, AM; Rohde, W; Volk, HD; Dorner, T; Burmester, GR; Hiepe, F
      Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls

      ANNALS OF THE RHEUMATIC DISEASES
    96. Touraine, F; Plu-Bureau, G; Beji, C; Mauvais-Jarvis, F; Kuttenn, F
      Long-term follow-up of 246 hyperprolactinemic patients

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    97. Sigurdardottir, GR; Nilsson, C; Odin, P; Grabowski, M
      Cardiovascular effects of domperidone in patients with Parkinson's diseasetreated with apomorphine

      ACTA NEUROLOGICA SCANDINAVICA
    98. Asano, S; Ueki, K; Suzuki, I; Kirino, T
      Clinical features and medical treatment of male prolactinomas

      ACTA NEUROCHIRURGICA
    99. Bragoni, M; Altieri, M; Di Piero, V; Padovani, A; Mostardini, C; Lenzi, GL
      Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke

      NEUROLOGICAL SCIENCES
    100. Randeva, HS; Davis, M; Prelevic, GM
      Prolactinoma and pregnancy

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:23:15